MUC1 and COVID-19: d’Alessandro et al. [27] and Letellier et al. [28] both investigated the prognostic utility of Krebs von den Lungen-6 (KL-6) in COVID-19 patients, focusing on its ability to differentiate between severity levels and predict outcomes, respectively.